Search research articles
Contact Us
Filters
Showing results (111-120 of 224) with videos related to
Page
of 23
Sort By:
Pharmacogenomics
|
November 7, 2019
Circulating biomarkers of response to immunotherapy in cancer treatment
Marzia Del Re, Giulia Gianfilippo, Stefania Crucitta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 11, 2025
Erratum to 'Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review' [Journal of Thoracic Oncology Volume 19 Issue 7 (2024) 973-983]
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, et al.
Oncotarget
|
June 16, 2016
A novel approach to inoperable or recurrent rectal cancer by chemoembolization: A new arrow in our quiver?
Roberto Bini, Simone Comelli, Renzo Leli, et al.
Pharmacogenomics
|
December 13, 2019
Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment
Marzia Del Re, Alfredo Addeo, Antonio Passaro, et al.
Nature Reviews. Clinical Oncology
|
October 6, 2021
Author Correction: EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
Alex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Frontiers in Medicine
|
August 17, 2019
The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy
Giuseppe Luigi Banna, Timothée Olivier, Francesco Rundo, et al.
Journal of Hematology & Oncology
|
October 26, 2022
Drugging KRAS: current perspectives and state-of-art review
Kaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 18, 2024
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, et al.
Journal of Thoracic Disease
|
January 22, 2024
Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma
Chu Qin, Xiaodong Fan, Xiaoyan Sai, et al.
Journal of Thoracic Disease
|
May 16, 2022
Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in <i>epidermal growth factor receptor</i> (<i>EGFR</i>)-mutant non-small cell lung cancer (NSCLC)
Giulio Metro, Angelo Bonaiti, Ilaria Birocchi, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 224) with videos related to
Sort By:
Page
of 23
Pharmacogenomics
|
November 7, 2019
Circulating biomarkers of response to immunotherapy in cancer treatment
Marzia Del Re, Giulia Gianfilippo, Stefania Crucitta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 11, 2025
Erratum to 'Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review' [Journal of Thoracic Oncology Volume 19 Issue 7 (2024) 973-983]
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, et al.
Oncotarget
|
June 16, 2016
A novel approach to inoperable or recurrent rectal cancer by chemoembolization: A new arrow in our quiver?
Roberto Bini, Simone Comelli, Renzo Leli, et al.
Pharmacogenomics
|
December 13, 2019
Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment
Marzia Del Re, Alfredo Addeo, Antonio Passaro, et al.
Nature Reviews. Clinical Oncology
|
October 6, 2021
Author Correction: EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
Alex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Frontiers in Medicine
|
August 17, 2019
The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy
Giuseppe Luigi Banna, Timothée Olivier, Francesco Rundo, et al.
Journal of Hematology & Oncology
|
October 26, 2022
Drugging KRAS: current perspectives and state-of-art review
Kaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 18, 2024
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, et al.
Journal of Thoracic Disease
|
January 22, 2024
Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma
Chu Qin, Xiaodong Fan, Xiaoyan Sai, et al.
Journal of Thoracic Disease
|
May 16, 2022
Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in <i>epidermal growth factor receptor</i> (<i>EGFR</i>)-mutant non-small cell lung cancer (NSCLC)
Giulio Metro, Angelo Bonaiti, Ilaria Birocchi, et al.
Page
of 23